Free Newsletter
New screening method for nanoparticles
Scientists at Brookhaven National Laboratory have developed a screening method to examine how newly made nanoparticles--particles with dimensions on the order of billionths of a meter--interact with human cells following exposure for various times and doses. This has led to the visualization of how human cells interact with some specific types of carbon nanoparticles. Their article is in the Journal of Physics.
- read the report on nanoparticles from Monsters and Critics
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: